Cilatil

New Zealand - English - Medsafe (Medicines Safety Authority)

Active ingredient:
Tadalafil 10 mg
Available from:
Viatris Limited
INN (International Name):
Tadalafil 10 mg
Dosage:
10 mg
Pharmaceutical form:
Film coated tablet
Composition:
Active: Tadalafil 10 mg Excipient: Colloidal silicon dioxide Croscarmellose sodium Lactose Magnesium stearate Microcrystalline cellulose Opadry yellow 32K520043 Poloxamer Povidone Purified water Sodium laurilsulfate
Prescription type:
Prescription
Manufactured by:
Mylan Laboratories Limited
Therapeutic indications:
· Erectile dysfunction (ED) in adult men. In order for Cilatil to be effective in treating ED, sexual stimulation is required. · Moderate to severe lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) in adult men · Adult men with co-existing ED and LUTS associated with BPH.
Product summary:
Package - Contents - Shelf Life: Blister pack, PVC/Aclar/Al or PVC/PE/PVDC/Al - 2 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Aclar/Al or PVC/PE/PVDC/Al - 4 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Aclar/Al or PVC/PE/PVDC/Al - 8 tablets - 24 months from date of manufacture stored at or below 25°C
Authorization number:
TT50-9174b
Authorization date:
2012-12-13

Similar products

Search alerts related to this product

Share this information